V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003491 | 210012420 | 1.57 | null | Palliative (P) | 2020-01-25 | 2020-08-15 | Carboplatin + Docetaxel | 02 | N | LETROZOLE + PALBOCICLIB | 100591677 |
| 210003497 | 210012421 | 1.61 | 144.4 | Adjuvant (A) | null | 2021-05-25 | Capecitabine | 02 | N | CAPECITABINE | 101680730 |
| 210003500 | 210012422 | 1.66 | 80.45 | Palliative (P) | 2020-03-08 | 2020-03-16 | Capecitabine | 02 | N | CAPECITABINE | 100859299 |
| 210003501 | 210012423 | 1.51 | 60 | null | 2020-09-01 | 2020-09-03 | CARBOPLATIN + GEMCITABINE | N | null | CARBOPLATIN + GEMCITABINE | 101043228 |
| 210003511 | 210012427 | 1.65 | 59.1 | null | 2017-11-26 | 2018-01-16 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101358189 |
| 210003512 | 210012428 | null | null | Neo-adjuvant (N) | 2019-06-19 | 2019-10-09 | null | 02 | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 101860377 |
| 210003517 | 210012430 | 1.68 | 56.2 | Neo-adjuvant (N) | 2022-01-14 | 2022-04-24 | Neratinib | 02 | N | NERATINIB | 100215560 |
| 210003523 | 210012431 | 1.54 | 128.6 | Adjuvant (A) | 2020-02-27 | 2020-02-29 | VINORELBINE | 02 | N | VINORELBINE | 101699740 |
| 210003532 | 210012433 | 1.69 | 97 | Palliative (P) | null | 2018-07-14 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100669115 |
| 210003534 | 210012435 | 1.63 | null | Adjuvant (A) | 2020-03-16 | 2020-03-31 | Eribulin | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100107612 |
| 210003536 | 210012436 | 1.61 | 85.4 | Palliative (P) | null | 2019-06-13 | Carboplatin + Docetaxel | 02 | N | TRIAL UNSPECIFIED | 101491473 |
| 210003538 | 210012437 | 1.57 | 58.2 | null | 2018-11-17 | 2018-11-23 | Capecitabine | 02 | null | CAPECITABINE | 101613746 |
| 210003539 | 210012438 | 1.59 | null | null | 2021-07-28 | 2021-07-28 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101108235 |
| 210003540 | 210012439 | 1.75 | 66.7 | Adjuvant (A) | 2019-05-15 | 2019-11-20 | Doce + Pertuzumab + Trastuz IV Load | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100590453 |
| 210003542 | 210012440 | 1.58 | 71.5 | Palliative (P) | null | 2020-01-18 | Capecitabine | null | N | CAPECITABINE | 101043355 |
| 210003544 | 210012442 | 1.65 | 75.5 | Neo-adjuvant (N) | null | 2022-03-11 | Capecitabine | 02 | N | CAPECITABINE | 101027596 |
| 210003545 | 210012443 | 1.52 | 71.8 | null | 2022-03-14 | 2022-03-29 | Eribulin | 02 | null | ERIBULIN | 100652043 |
| 210003551 | 210012444 | 1.75 | 102.55 | Curative (C) | null | 2020-08-04 | Eribulin | 02 | N | ERIBULIN | 100945543 |
| 210003561 | 210012447 | 1.75 | 63.7 | Adjuvant (A) | 2017-03-13 | 2017-03-29 | null | null | N | CAPECITABINE | 100160981 |
| 210003564 | 210012448 | 1.52 | 94.1 | Palliative (P) | 2021-05-20 | 2021-07-24 | Paclitaxel albumin (Abraxane) 21day | 02 | N | LETROZOLE + PALBOCICLIB | 100430523 |
| 210003565 | 210012449 | null | null | null | 2019-03-05 | 2020-02-20 | Eribulin | null | null | ERIBULIN | 101379463 |
| 210003572 | 210012450 | null | 86.4 | null | 2018-07-20 | 2018-08-24 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101700148 |
| 210003580 | 210012452 | 1.6 | 82 | Adjuvant (A) | 2020-05-31 | 2020-06-14 | null | 02 | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101198518 |
| 210003582 | 210012453 | 1.55 | 74.25 | null | 2018-05-11 | 2018-08-11 | Neratinib | 02 | null | NERATINIB | 101592335 |
| 210003588 | 210012454 | 1.76 | 86 | Palliative (P) | 2018-10-30 | 2018-12-26 | Epirubicin (weekly) | 02 | N | LETROZOLE + PALBOCICLIB | 100005171 |
| 210003598 | 210012459 | 1.57 | 62.7 | null | 2021-01-23 | 2021-01-30 | ABEMACICLIB + FULVESTRANT | 02 | null | EC | 100106900 |
| 210003603 | 210012461 | null | null | null | 2017-07-29 | 2017-08-08 | Neratinib | 02 | null | NERATINIB | 100567393 |
| 210003608 | 210012463 | 1.53 | 87.2 | Palliative (P) | null | 2018-05-05 | null | 02 | N | EC | 101459971 |
| 210003609 | 210012464 | 1.73 | 72.7 | Palliative (P) | 2020-10-19 | 2021-02-25 | Eribulin | 02 | N | ERIBULIN | 101869396 |
| 210003613 | 210012466 | 1.64 | 53.15 | null | 2017-08-16 | 2018-01-22 | null | 02 | null | TRASTUZUMAB EMTANSINE | 100164255 |
| 210003614 | 210012467 | 1.65 | 68.5 | Neo-adjuvant (N) | 2019-08-18 | 2019-09-01 | Palbociclib | 02 | N | LETROZOLE + PALBOCICLIB | 100051436 |
| 210003619 | 210012469 | 1.76 | 124 | Palliative (P) | 2014-12-19 | 2018-09-01 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100762088 |
| 210003620 | 210012470 | 1.6 | 80.2 | null | 2020-05-18 | 2020-05-29 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + PACLITAXEL | 101692920 |
| 210003629 | 210012473 | 1.57 | 53.1 | Neo-adjuvant (N) | null | 2018-02-17 | EC | null | N | EC | 101399238 |
| 210003634 | 210012475 | 1.53 | 80.2 | Curative (C) | 2017-10-12 | 2017-12-22 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101537298 |
| 210003637 | 210012477 | 1.62 | 97.9 | null | 2021-03-15 | 2021-03-30 | null | 02 | null | LETROZOLE + PALBOCICLIB | 100715250 |
| 210003638 | 210012478 | 1.78 | 66.95 | null | 2017-06-03 | 2017-09-21 | null | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100694326 |
| 210003640 | 210012479 | null | null | null | 2016-12-11 | 2021-02-16 | Capecitabine | 02 | null | CAPECITABINE | 100230306 |
| 210003641 | 210012480 | 1.7 | 90.2 | null | 2019-09-21 | 2019-12-28 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100075897 |
| 210003643 | 210012481 | null | 65.5 | null | 2021-04-20 | 2021-05-05 | ATEZOLIZUMAB + NAB PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 101860198 |
| 210003645 | 210012482 | 1.56 | 77.4 | null | 2020-03-08 | 2020-03-24 | TCH (21 day Trastuzumab) Maint | 02 | null | EPIRUBICIN | 100213240 |
| 210003646 | 210012483 | 1.75 | 72 | null | 2019-09-28 | 2019-10-06 | Capecitabine | 02 | null | CAPECITABINE | 100777280 |
| 210003654 | 210012487 | 1.71 | 81 | null | 2019-06-26 | 2022-05-05 | Olaparib | 02 | null | PACLITAXEL + TRASTUZUMAB | 101430286 |
| 210003661 | 210012489 | 1.81 | 93 | null | null | 2020-09-24 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 101142984 |
| 210003669 | 210012493 | 1.54 | 74 | Adjuvant (A) | 2019-03-04 | 2019-03-05 | null | 02 | N | CAPECITABINE | 101195971 |
| 210003673 | 210012495 | 1.64 | null | Neo-adjuvant (N) | 2017-03-13 | 2017-06-04 | GemCarbo Days 1+8 | N | N | CARBOPLATIN + GEMCITABINE | 100881847 |
| 210003676 | 210012497 | 1.59 | 65.2 | Palliative (P) | 2020-02-29 | 2020-03-11 | Paclitaxel albumin (Abraxane) 21day | 02 | N | ROSCO TRIAL | 100223679 |
| 210003677 | 210012498 | 1.75 | 54 | Adjuvant (A) | 2019-04-09 | 2019-06-20 | null | 02 | N | EPIRUBICIN | 101174176 |
| 210003678 | 210012499 | 1.61 | 86 | null | 2017-07-19 | 2017-07-19 | Pertuzumab + Trastuzumab IV | null | null | PERTUZUMAB + TRASTUZUMAB | 100035580 |
| 210003679 | 210012500 | 1.66 | 86.6 | null | 2019-03-25 | 2019-07-15 | Capecitabine | 02 | null | CAPECITABINE | 101863233 |